Search Results

Search Results for


Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer

Continue Reading »

Randomized Phase II Trial of Encorafenib and Cetuximab with or Without Nivolumab (NSC #748726) for Patients with Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable Colorectal Cancer

Continue Reading »

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)

Continue Reading »

CORRECT-MRD II: Second Colorectal Cancer Clinical Validation Study to Predict Recurrence Using a Circulating Tumor DNA Assay to Detect Minimal Residual Disease

Continue Reading »
EA2201 (Suspended)

Testing Nivolumab and Ipilimumab With Short-Course Radiation in Advanced Rectal Cancer( Suspended)

Continue Reading »
NRG-GI005 (Suspended)

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery (Suspended)

Continue Reading »

Testing Diet Intervention Versus Non-Diet Intervention for Management of Bowel Symptoms in Rectal Cancer Survivors

Continue Reading »

Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer

Continue Reading »

Search Again